Not Tagged
eqrx
['hodgkin', 'lymphoma', 'eqrx']
today at #asco22: an oral presentation of new phase 2 data on our investigational pd-l1 inhibitor in enktl, a rare form of #nonhodgkinlymphoma with currently no approved treatments in the u.s. abstract #7501: 
EQRx is a new type of pharmaceutical company committed to developing & delivering innovative medicines to patients at RADICALLY lower prices. #RemakingMedicine